MX173854B - Procedimiento para la preparacion de nuevos derivados del acido glutamico y producto obtenido - Google Patents

Procedimiento para la preparacion de nuevos derivados del acido glutamico y producto obtenido

Info

Publication number
MX173854B
MX173854B MX010556A MX1055688A MX173854B MX 173854 B MX173854 B MX 173854B MX 010556 A MX010556 A MX 010556A MX 1055688 A MX1055688 A MX 1055688A MX 173854 B MX173854 B MX 173854B
Authority
MX
Mexico
Prior art keywords
glutamic acid
procedure
preparation
product obtained
amino acid
Prior art date
Application number
MX010556A
Other languages
English (en)
Other versions
MX10556A (es
Inventor
Constantin Agouridas
Patrick Fauveau
Chantal Damais
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of MX10556A publication Critical patent/MX10556A/es
Publication of MX173854B publication Critical patent/MX173854B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un procedimiento de preparación en todas sus formas isómeras o en formas de mezclas de isómeros de los derivados del ácido glutámico así como sus sales de adición con los ácidos minerales u orgánicos o con las bases, caracterizados porque los mismsos reponden a la fórmula general (I): en la cual el ácido glutámico tiene configuración D ó L, caracterizado porque se hace reaccionar un derivado del ácido glutámico de fórmula (II): con un derivado de fórmula (III) que puede presentarse en forma de isómeros separados o en forma de mezclas de isómeros: para obtener un producto de fórmulas, que se aisla y, si se desea, se salifica, o se somete si es necesario a una de las reacciones siguientes, en cualquier orden: a) si X' o Y' representa un radical COO-Alk3: descarboxilación b) desprotección de las funciones amino, c) desalquilación de las funciones hidroxilo, d) amidificación de las funciones amino libres por un amino ácido o un peptido constituído por 2, 3 ó 4 aminoácidos cuya función amino está protegida, y desprotección posterior de esta función amino, e) esterificación o salificación por una base de las funciones carboxi, f) salificación por ácido de las funciones amino.
MX010556A 1987-02-26 1988-02-25 Procedimiento para la preparacion de nuevos derivados del acido glutamico y producto obtenido MX173854B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8702547A FR2611721B1 (fr) 1987-02-26 1987-02-26 Nouveaux derives de l'acide glutamique, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant

Publications (2)

Publication Number Publication Date
MX10556A MX10556A (es) 1993-09-01
MX173854B true MX173854B (es) 1994-04-07

Family

ID=9348338

Family Applications (1)

Application Number Title Priority Date Filing Date
MX010556A MX173854B (es) 1987-02-26 1988-02-25 Procedimiento para la preparacion de nuevos derivados del acido glutamico y producto obtenido

Country Status (12)

Country Link
US (1) US5089476A (es)
EP (1) EP0284461B1 (es)
JP (1) JPH0617350B2 (es)
KR (1) KR880009989A (es)
AT (1) ATE64374T1 (es)
CA (1) CA1310443C (es)
DE (1) DE3863214D1 (es)
ES (1) ES2029040T3 (es)
FR (1) FR2611721B1 (es)
GR (1) GR3002416T3 (es)
MX (1) MX173854B (es)
PT (1) PT86835B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645858B1 (fr) * 1989-04-18 1991-06-14 Roussel Uclaf Nouveaux derives insatures de l'acide 2,6-diamino heptanedioique, leur procede de preparation et leur application comme medicaments
FR2651777B1 (fr) * 1989-09-12 1991-12-13 Roussel Uclaf Nouveaux derives dicarboxyliques renfermant un heterocycle azote ou oxygene, leur procede de preparation et leur application comme medicaments.
US8420144B2 (en) * 2005-11-09 2013-04-16 Ajinomoto Co., Inc. Kokumi-imparting agent, method of using, and compositions containing same
WO2007055388A2 (en) * 2005-11-09 2007-05-18 Ajinomoto Co., Inc. Calcium receptor activator
WO2007055393A1 (en) * 2005-11-09 2007-05-18 Ajinomoto Co., Inc. Kokumi-imparting agent
NZ581627A (en) * 2007-05-08 2012-07-27 Ajinomoto Kk Low fat food with a calcium receptor activating additive
JPWO2009107660A1 (ja) * 2008-02-25 2011-07-07 味の素株式会社 糖尿病又は肥満病の予防又は治療剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
FR2566410A1 (fr) * 1984-06-20 1985-12-27 Delalande Sa Nouveaux derives de l'acide diaminopimelique, leur procede de preparation et leur application en therapeutique
US4730006A (en) * 1986-01-27 1988-03-08 Merrell Dow Pharmaceuticals Inc. Derivatives of 2,6-diamino-3-haloheptanedioic acid

Also Published As

Publication number Publication date
ES2029040T3 (es) 1992-07-16
FR2611721B1 (fr) 1990-01-26
EP0284461A1 (fr) 1988-09-28
JPS63233961A (ja) 1988-09-29
GR3002416T3 (en) 1992-12-30
KR880009989A (ko) 1988-10-06
EP0284461B1 (fr) 1991-06-12
JPH0617350B2 (ja) 1994-03-09
CA1310443C (fr) 1992-11-17
ATE64374T1 (de) 1991-06-15
PT86835A (pt) 1988-03-01
US5089476A (en) 1992-02-18
PT86835B (pt) 1992-05-29
DE3863214D1 (de) 1991-07-18
MX10556A (es) 1993-09-01
FR2611721A1 (fr) 1988-09-09

Similar Documents

Publication Publication Date Title
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
GR3001889T3 (en) Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same
ES517637A0 (es) Un procedimiento de preparacion de los acidos(oxo-4-4h-(1)-benzopiran-8-il)-alcanoicos.
JPS57108073A (en) N-substituted omega-(2-oxo-4-imidazoline- 1-yl)alkanoic acid compound
ES510599A0 (es) Procedimiento para la preparacion de acidos (2-oxo-3-tetrahidrotienilcarbamoil)-alquiltio aceticos.
MX10556A (es) Procedimiento para la preparacion de nuevos derivados del acido glutamico y producto obtenido.
MX167455B (es) Procedimiento para la preparacion de acidos oxoftalazinil aceticos
HU902612D0 (en) Process for the preparation of 4-phenylmethyl-1h-indole derivatives
DE3789064D1 (de) Verfahren zur Herstellung von in Stellung 3 durch eine halogenierte gesättigte Kette substituierten Cyclopropancarbonsäurederivaten.
BR8802816A (pt) Derivados do acido(2-ciano-9-oximinoacetil)-aminico,processo para sua preparacao,composicoes praguicidas,processos para combater pragas e para a preparacao de composicoes
IT1157249B (it) Procedimento per la sintesi di eteri di n-propanol-diammina
BR8802815A (pt) Derivados de(2-ciano-2-oximinoacetil)-aminoacidos processo para sua preparacao,composicoes praguicidas,processos para o combate a parasitas e para a preparacao de composicoes
PT88926A (pt) Processo para a preparacao de derivados do acido aminopimelico e de compostos farmaceuticos que o contem
DE3469527D1 (en) Nortropine derivative, process for its preparation and its use
IN170286B (es)
DE59202229D1 (de) Verfahren zur Herstellung substituierter Indole.
IT1240322B (it) Acidi 2-(2,4-diaril-ossazol-5-il)-alcancarbossilici,loro esteri e salimetodi per la loro preparazione e composizioni farmaceutiche che li contengono
ES2095831T3 (es) Acidos tetrahidro-4-fenilimino-3-tiofeno-aceticos.
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren